Lipid Metabolism and Osteoarthritis Progression

Osteoarthritis is increasingly recognised not merely as a mechanical wear-and-tear disorder but as a metabolic disease in which lipid homeostasis plays a central role. Lipids such as cholesterol, fatty acids and lipoproteins influence cartilage health, synovial membrane function and subchondral bone remodelling. Aberrant lipid accumulation in chondrocytes and synovial tissues can trigger inflammatory mediators, oxidative stress and matrix-degrading enzymes, accelerating cartilage erosion and osteophyte formation. Conversely, protective lipid fractions, notably high-density lipoproteins, may counteract inflammatory cascades and preserve joint integrity. Advances in molecular biology have uncovered pathways by which lipid species modulate gene expression, influence cellular senescence and alter extracellular matrix composition. Therapeutic strategies targeting lipid metabolism—ranging from lifestyle interventions and statins to RNA-based and small-molecule modulators—offer prospects for disease modification. A deeper understanding of lipid networks in joint tissues holds promise for stratified treatments that address metabolic drivers of osteoarthritis alongside mechanical factors, with global health implications for ageing populations and the rising prevalence of obesity and metabolic syndrome.

Research from Nature Portfolio

A long-term population study has demonstrated an inverse relationship between high-density lipoprotein cholesterol levels and the incidence of radiographic hand osteoarthritis over an 11-year period, suggesting a protective role of this lipid fraction in joint preservation. Analyses of serum lipids revealed that elevated triglyceride concentrations were linked to increased osteoarthritis risk, whereas total and low-density lipoprotein cholesterol showed no consistent association, highlighting the importance of lipid subtypes in disease susceptibility.

Lipid Metabolism and Osteoarthritis Progression publication trend

The graph below shows the total number of articles in lipid metabolism and osteoarthritis progression across all publications each year (not limited to Nature Index journals).

Technical terms

Lipid metabolism: Biological processes governing the synthesis, transport and breakdown of fats and lipoproteins within cells and tissues.

Osteoarthritis: Chronic joint condition characterised by progressive cartilage deterioration, synovial inflammation and subchondral bone remodelling.

Chondrocyte: Cartilage cell responsible for producing and maintaining the extracellular matrix in articular cartilage.

Synovial inflammation: Inflammatory response in the synovial membrane lining joints, leading to pain, swelling and cartilage degradation.

Circular RNA (circRNA): Non-coding RNA molecules forming covalently closed loops that modulate gene expression and protein stability.

High-density lipoprotein (HDL): Lipoprotein fraction that facilitates reverse cholesterol transport and may exert anti-inflammatory effects in joints.

References

1. Risk of metabolic abnormalities in osteoarthritis: a new perspective to understand its pathological mechanisms. Bone Research (2023).
2. Serum Lipid Levels and Risk Of Hand Osteoarthritis: The Chingford Prospective Cohort Study. Scientific Reports (2017).
3. Circular RNA circARPC1B functions as a stabilisation enhancer of Vimentin to prevent high cholesterol‐induced articular cartilage degeneration. Clinical and Translational Medicine (2023).
4. Intensive cholesterol-lowering treatment reduces synovial inflammation during early collagenase-induced osteoarthritis, but not pathology at end-stage disease in female dyslipidemic E3L.CETP mice. Osteoarthritis and Cartilage (2023).